Cardiovascular News

4 days ago | cardiovascularnews.com | Eva Malpass

FastWave Medical has announced the successful completion of initial first-in-human (FIH) procedures in its feasibility study of Sola, the coronary laser intravascular lithotripsy (IVL) system. The multicentre study will assess Sola’s safety and performance in patients with calcified coronary artery disease. Sola is a rupture-resistant balloon catheter designed to help physicians treat hardened calcium in blood vessels with precision and control.

1 month ago | cardiovascularnews.com | Jocelyn Hudson

Inquis Medical recently announced results from its AVENTUS trial evaluating the safety and efficacy of the company’s Aventus thrombectomy system. The results were presented by Jun Li (University Hospitals Harrington Heart & Vascular Institute, Cleveland, USA), the trial’s national co-principal investigator, at the 2025 Society of Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions (1–3 May, Washington, DC, USA).

1 month ago | cardiovascularnews.com | Eva Malpass

A STRIKE-PE interim analysis of clinical outcomes of acute pulmonary embolism (PE) patients with or without syncope—an indicator of compromised cardiac output and so increased short-term mortality—has found that patients with syncope who had a higher right/left ventricle (RV/LV) ratio at baseline were restored to a condition similar to patients without syncope following treatment with the Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device.

2 months ago | cardiovascularnews.com | Jocelyn Hudson

Evident Vascular has announced the successful closing of its Series B financing with new investors Shangbay Capital and two undisclosed multinational strategics joining founding investor Vensana Capital. A press release details that the funding will accelerate development of the company’s advanced intravascular ultrasound (IVUS) technology designed to enhance vascular imaging and patient outcomes and support 510(k) US Food and Drug Administration (FDA) clearance ahead of US market launch.

Jan 23, 2025 | cardiovascularnews.com | Eva Malpass

FastWave Medical has announced the issuance of its seventh utility patent by the US Patent and Trademark Office (USPTO). This patent covers FastWave’s laser intravascular lithotripsy (IVL) technology, specifically engineered to address calcified arteries. “Calcified arteries remain one of the most difficult conditions to treat in our field,” said interventional cardiologist Amir Kaki (Henry Ford St. John’s Hospital, Detroit, USA).